𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new restriction-site polymorphism in exon 18 of the low density lipoprotein receptor (LDLR) gene

✍ Scribed by David H. Kass; Mark A. Batzer; Prescott L. Deininger


Publisher
Springer
Year
1995
Tongue
English
Weight
205 KB
Volume
95
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Detection of a frequent polymorphism in
✍ L. Warnich; M. J. Kotze; E. Langenhoven; A. E. Retief πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 90 KB

DNA sequencing of enzymatically-amplified exons of the low-density lipoprotein receptor gene from several individuals revealed a polymorphism in exon 10 of the gene. The codon for arginine 450 was converted from AGG to AGA in some alleles.

A new informative Alw 26 I polymorphism
✍ Marie-Laure Kottler; Jean Pierre Lagarde; Karin Dahan; Leila Zekraoui; Alain Rai πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 41 KB πŸ‘ 2 views

Using DNA sequencing of the coding and exon flanking regions of the low density lipoprotein receptor (LDLR) gene we identified an Alw26 I site in exon 10 by a transition G1426A. The alleles are represented by one uncut fragment (A1 = 108 bp) or two fragments (A2 = 82bp and 26 pb). Two other fragment

Characterization and geographic distribu
✍ George Miltiadous; Moses Elisaf; Helen Bairaktari; Stavroulla L. Xenophontos; Pa πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 1 views

Familial Hypercholesterolaemia (FH) is a clinical syndrome characterised by elevated serum total cholesterol levels due to an increase in low density lipoprotein (LDL) cholesterol, by tendon xanthomata and clinical manifestations of ischaemic heart disease in early life. Typically, it results from m

Low density lipoprotein receptor (LDLR)
✍ Jian Wang; Erin Huff; Lenny Janecka; Robert A. Hegele πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 20 KB πŸ‘ 1 views

Heterozygous familial hypercholesterolemia (FH) is a relatively common autosomal dominant disorder, which is characterized by elevated plasma concentrations of low density lipoprotein (LDL) cholesterol and early coronary heart disease. FH results from mutations in the gene encoding the LDL receptor

Non-physiological overexpression of the
✍ Guenter Cichon; Thomas Willnow; Susanne Herwig; Wolfgang Uckert; Peter LΓΆser; Ha πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 275 KB

## Background: Gene therapy of familial hypercholesterolemia (fh) requires successful transfer and lifelong expression of a functional low density lipoprotein receptor (ldlr) gene in the liver. most of the vector systems currently employed for gene therapy use promoter elements which do not modulat